Fecal Calprotectin Collection Protocol

Study Purpose

The primary objective is to obtain stool samples from subjects diagnosed with , and displaying signs and/or symptoms of IBD and/or IBS will be evaluated in this study. Eligible subjects require a diagnostic colonoscopy with possible biopsy and clinical evaluation.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 4 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Subject is of either gender and ≥ 4 years of age.
  • - Subject is showing signs and symptoms of IBD and/or IBS.
  • - Diagnosis of IBD, IBS or other gastrointestinal disorder is performed by colonoscopy.
  • - Subject or authorized legal representative is willing and able to sign the IRB approved Informed Consent form or able to provide Informed Consent in accordance with 21 CFR 50 CFR 50 Subpart B.
  • - Subject is able to understand and follow study sample collection procedure.

Exclusion Criteria:

  • - Subject has undergone a surgical resection or diversion procedure.
  • - Subject is currently taking NSAIDS (non-steroidal anti-inflammatory drugs, i.e. ibuprofen, Advil, Motrin, Naproxen, Aleve including regular dose and low dose aspirin) within 7 days of colonoscopy and sample collection.
  • - Subject who has taken immunomodulators or biologic therapies within the previous 6 months of colonoscopy and sample collection.
  • - Subject who is currently pregnant or lactating.
  • - Subject is unable or unwilling to follow informed consent.
  • - Inability or unwilling to perform required study procedures.

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT03143517
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

DiaSorin Inc.
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

N/A
Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Inflammatory Bowel Diseases, Irritable Bowel Syndrome, Ulcerative Colitis, Crohn Disease, Indeterminate Colitis, Chronic Diarrhea, Celiac Disease, Diverticulitis, Abdominal Pain, Distension, Weight Loss, Food Intolerance, Constipation
Additional Details

Stools will be collected and tested, at a later date, in a clinical performance study with an investigational Calprotectin assay. This study will be coordinated by the Sponsor.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

One (1) Facility in Arkansas, Little Rock, Arkansas

Status

Recruiting

Address

One (1) Facility in Arkansas

Little Rock, Arkansas, 72117

Site Contact

651-439-9710

One (1) Location in California, Mission Hills, California

Status

Not yet recruiting

Address

One (1) Location in California

Mission Hills, California, 91345

Site Contact

651-439-9710

Colorado Springs, Colorado

Status

Recruiting

Address

One (1) Location in Colorado Springs, Colorado

Colorado Springs, Colorado, 80907

Site Contact

651-439-9710

One (1) Location in Miami, Florida, Miami, Florida

Status

Recruiting

Address

One (1) Location in Miami, Florida

Miami, Florida, 33134

Site Contact

651-439-9710

One (1) Location in St. Augustine, FL, Saint Augustine, Florida

Status

Recruiting

Address

One (1) Location in St. Augustine, FL

Saint Augustine, Florida, 32086

Site Contact

651-439-9710

One (1) Location in New York, New York, New York, New York

Status

Recruiting

Address

One (1) Location in New York, New York

New York, New York, 33134

Site Contact

651-439-9710

One (1) Location in North Carolina, Asheville, North Carolina

Status

Recruiting

Address

One (1) Location in North Carolina

Asheville, North Carolina, 28801

Site Contact

651-439-9710

The content provided by the Celiac Disease Foundation on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation. For a full description of terms please refer to: Privacy Policy and Terms of Use.